Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Circadian sleep–wake rhythm disturbances in end-stage renal disease

Abstract

End-stage renal disease (ESRD) is an increasing health problem worldwide. Given the increasing prevalence of this disease, the high cost of hemodialysis treatment and the burden of hemodialysis on a patient's life, more research on improving the clinical outcomes and the quality of life of hemodialysis-treated patients is warranted. Sleep disturbances are much more prevalent in the dialysis population than in the general population. Several studies investigating the effect and importance of sleep problems on quality of life in dialysis patients revealed that sleep disturbances have a major influence on the vitality and general health of these patients. Sleep disturbances in this patient group are caused both by the pathology of the renal disease and by the dialysis treatment itself. This Review focuses on circadian sleep–wake rhythm disturbances in individuals with ESRD. The possible external and internal influences on sleep–wake rhythmicity in patients with ESRD, such as the effect of dialysis, medications, melatonin and biochemical parameters, are presented. In addition, possible approaches for strengthening the synchronization of the circadian sleep–wake rhythm, such as nocturnal hemodialysis, exogenous melatonin, dialyzate temperature, exogenous erythropoietin, use of bright light and exercise during dialysis treatment, are explored. Further research in this area is warranted, and a greater awareness of sleep problems is needed to improve the quality of life of patients with ESRD.

Key Points

  • Sleep disturbances are much more prevalent in patients with end-stage renal disease (ESRD) than in the general population

  • Several studies on the impact and importance of sleep problems on quality of life in patients on dialysis revealed that sleep disturbances have a major effect on the vitality and general health of these patients

  • Sleep disturbances in patients on dialysis might be caused by the pathology of the renal disease as well as by the dialysis treatment itself

  • External and internal factors that might be associated with disrupted sleep–wake rhythmicity in patients with ESRD include dialysis, medications, melatonin rhythm and biochemical parameters

  • Approaches that might be useful in treating disturbances in the circadian sleep–wake rhythm in patients with ESRD include nocturnal dialysis, exogenous melatonin, lowering dialyzate temperature, exogenous erythropoietin, bright light and intradialytic exercise

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: The human circadian clock.
Figure 2: Factors influencing the sleep–wake cycle.
Figure 3: Synthesis of melatonin from tryptophan.
Figure 4: The mechanism through which light inhibits melatonin secretion by the pineal gland involving the neural pathway originating in the retina and passing through the suprachiasmatic nucleus in the brain, to reach pinealocytes via adrenergic nerves and adrenergic receptors, and subsequently to the periphery.

References

  1. Parker, K. P. Sleep disturbances in dialysis patients. Sleep Med. Rev. 7, 131–143 (2003).

    Article  PubMed  Google Scholar 

  2. Molzahn, A. E., Northcott, H. C. & Dossetor, J. B. Quality of life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians. ANNA J. 24, 325–333 (1997).

    CAS  PubMed  Google Scholar 

  3. Parker, K. P., Bliwise, D. L. & Rye, D. B. Hemodialysis disrupts basic sleep regulatory mechanisms: building hypotheses. Nurs. Res. 49, 327–332 (2000).

    Article  CAS  PubMed  Google Scholar 

  4. Cuninkova, L. & Brown, S. A. Peripheral circadian oscillators: interesting mechanisms and powerful tools. Ann. N. Y. Acad. Sci. 1129, 358–370 (2008).

    Article  PubMed  Google Scholar 

  5. Yoo, S. H. et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl Acad. Sci. USA 101, 5339–5346 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. Borbely, A. A. & Achermann, P. Concepts and models of sleep regulation: an overview. J. Sleep Res. 1, 63–79 (1992).

    Article  CAS  PubMed  Google Scholar 

  7. McGinty, D. & Szymusiak, R. Sleep promoting mechanisms in mammals. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 169–184 (Elsevier Saunders, Philadelphia, 2005).

    Chapter  Google Scholar 

  8. American Academy of Sleep Medicine. International classification of sleep disorders, Diagnostic and coding manual 2nd edn. (American Academy of Sleep Medicine, Westchester, IL, 2005).

  9. Reid, K. J. & Zee, P. C. Circadian disorders of the sleep-wake cycle. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 691–702 (Elsevier Saunders, Philadelphia, 2005).

    Chapter  Google Scholar 

  10. Carskadon, M. A. & Dement, W. C. Normal human sleep: an overview. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 13–23 (Elsevier Saunders, Philadelphia, 2005).

    Chapter  Google Scholar 

  11. Hirshkowitz, M. Normal human sleep: an overview. Med. Clin. North Am. 88, 551–565 (2004).

    Article  PubMed  Google Scholar 

  12. Bonnet, M. H. Acute sleep deprivation. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 59–60 (Elsevier Saunders, Philadelphia, 2005).

    Google Scholar 

  13. Koch, B. C., Nagtegaal, J. E., Hagen, E. C., ter Wee, P. M. & Kerkhof, G. A. Different melatonin rhythms and sleep-wake rhythms in patients on peritoneal dialysis, daytime hemodialysis and nocturnal hemodialysis. Sleep Med. (in press).

  14. Carskadon, M. A. & Rechtschaffen, A. Monitoring and staging human sleep. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 1359–1378 (Elsevier Saunders, Philadelphia, 2005).

    Chapter  Google Scholar 

  15. Claustrat, B., Brun, J. & Chazot, G. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9, 11–24 (2005).

    Article  PubMed  Google Scholar 

  16. Scheer, F. A. & Czeisler, C. A. Melatonin, sleep, and circadian rhythms. Sleep Med. Rev. 9, 5–9 (2005).

    Article  PubMed  Google Scholar 

  17. Konturek, S. J., Konturek, P. C., Brzozowski, T. & Bubenik, G. A. Role of melatonin in upper gastrointestinal tract. J. Physiol. Pharmacol. 58 (Suppl. 6), 23–52 (2007).

    PubMed  Google Scholar 

  18. Waldhauser, F. & Dietzel, M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann. N. Y. Acad. Sci. 453, 205–214 (1985).

    Article  CAS  PubMed  Google Scholar 

  19. Iguichi, H., Kato, K. I. & Ibayashi, H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J. Clin. Endocrinol. Metab. 55, 27–29 (1982).

    Article  CAS  PubMed  Google Scholar 

  20. Zhdanova, I. V. & Wurtman, R. J. Efficacy of melatonin as a sleep-promoting agent. J. Biol. Rhythms 12, 644–650 (1997).

    Article  CAS  PubMed  Google Scholar 

  21. Czeisler, C. A., Buxton, O. M. & Singh Khalsa, S. B. The human circadian timing system and sleep-wake regulation. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 388 (Elsevier Saunders, Philadelphia, 2005).

    Google Scholar 

  22. Lewy, A. J. & Sack, R. L. The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int. 6, 93–102 (1989).

    Article  CAS  PubMed  Google Scholar 

  23. Akerstedt, T., Fröberg, J. E., Friberg, Y. & Wetterberg, L. Melatonin excretion, body temperature and subjective arousal during 64 hours of sleep deprivation. Psychoneuroendocrinology 4, 219–225 (1979).

    Article  CAS  PubMed  Google Scholar 

  24. Tzischinsky, O., Shlitner, A. & Lavie, P. l. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J. Biol. Rhythms 8, 199–209 (1993).

    Article  CAS  PubMed  Google Scholar 

  25. Nagtegaal, E. et al. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther. Drug Monit. 20, 181–183 (1998).

    Article  CAS  PubMed  Google Scholar 

  26. Cagnacci, A., Elliott, J. A. & Yen, S. S. Melatonin: a major regulator of the circadian rhythm of core temperature in humans. J. Clin. Endocrinol. Metab. 75, 447–452 (1992).

    CAS  PubMed  Google Scholar 

  27. Ekmekcioglu, C. Melatonin receptors in humans: biological role and clinical relevance. Biomed. Pharmacother. 60, 97–108 (2006).

    Article  CAS  PubMed  Google Scholar 

  28. Markus, R. P., Ferreira, Z. S., Fernandes, P. A. & Cecon, E. The immune-pineal axis: a shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 14, 126–133 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Walker, S., Fine, A. & Kryger, M. H. Sleep complaints are common in a dialysis unit. Am. J. Kidney Dis. 26, 751–756 (1995).

    Article  CAS  PubMed  Google Scholar 

  30. Mucsi, I. et al. Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrol. Dial. Transplant. 19, 1815–1822 (2004).

    Article  PubMed  Google Scholar 

  31. Sabbatini, M. A. et al. Insomnia in maintenance haemodialysis patients. Nephrol. Dial. Transplant. 17, 852–856 (2002).

    Article  PubMed  Google Scholar 

  32. Merlino, G. et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol. Dial. Transplant. 21, 184–190 (2006).

    Article  PubMed  Google Scholar 

  33. Koch, B. C. et al. Subjective sleep efficiency of haemodialysis patients. Clin. Nephrol. 70, 411–418 (2008).

    Article  CAS  PubMed  Google Scholar 

  34. Parker, K. P., Bliwise, D. L., Bailey, J. L. & Rye, D. B. Polysomnographic measures of nocturnal sleep in patients on chronic, intermittent daytime haemodialysis vs those with chronic kidney disease. Nephrol. Dial. Transplant. 20, 1422–1428 (2005).

    Article  PubMed  Google Scholar 

  35. Mendelssohn, D. et al. Sleep disorders and quality of life in chronic kidney disease patients in the predialysis stage [abstract]. J. Am. Soc. Nephrol. 15, 132A (2004).

    Google Scholar 

  36. Barrett, B. J., Vavasour, H. M., Major, A. & Parfrey, P. S. Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron 55, 10–15 (1990).

    Article  CAS  PubMed  Google Scholar 

  37. Holley, J. L., Nespor, S. & Rault, R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am. J. Kidney Dis. 19, 156–161 (1992).

    Article  CAS  PubMed  Google Scholar 

  38. Bro, S. et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit. Dial. Int. 19, 526–533 (1999).

    CAS  PubMed  Google Scholar 

  39. Tang, S. C. et al. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol. 17, 2607–2616 (2006).

    Article  PubMed  Google Scholar 

  40. Dinarello, C. A. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int. Suppl. 38 (Suppl.), S68–S77 (1992).

    CAS  PubMed  Google Scholar 

  41. Herbelin, A., Nguyen, A. T., Zingraff, J., Ureña, P. & Descamps-Latscha, B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int. 37, 116–125 (1990).

    Article  CAS  PubMed  Google Scholar 

  42. Zaoui, P. & Hakim, R. M. The effects of the dialysis membrane on cytokine release. J. Am. Soc. Nephrol. 4, 1711–1718 (1994).

    CAS  PubMed  Google Scholar 

  43. Lack, L. C. & Lushington, K. The rhythms of human sleep propensity and core body temperature. J. Sleep Res. 5, 1–11 (1996).

    Article  CAS  PubMed  Google Scholar 

  44. Lack, L. C., Gradisar, M., Van Someren, E. J., Wright, H. R. & Lushington, K. The relationship between insomnia and body temperatures. Sleep Med. Rev. 12, 307–317 (2008).

    Article  PubMed  Google Scholar 

  45. Campbell, S. S., Dawson, D. & Zulley, J. When the human circadian system is caught napping: evidence for endogenous rhythms close to 24 hours. Sleep 16, 638–640 (1993).

    CAS  PubMed  Google Scholar 

  46. Blagg, C. R. Acute complications associated with hemodialysis. In Replacement of Renal Function by Dialysis: a Textbook of Dialysis (Ed. Maher, J. F.) 750–771 (Kluwer Academic, Boston, 1989).

    Chapter  Google Scholar 

  47. Plum, F. & Posner, J. B. Multifocal, diffuse, and metabolic brain diseases causing stupor or coma. In The Diagnosis of Stupor and Coma (Eds Plum, F. & Posner, J. B.) 177–303 (F. A. Davis, Philadelphia, 1985).

    Google Scholar 

  48. DiFresco, V., Landman, M., Jaber, B. L. & White, A. C. Dialysis disequilibrium syndrome: an unusual cause of respiratory failure in the medical intensive care unit. Intensive Care Med. 26, 628–630 (2000).

    Article  CAS  PubMed  Google Scholar 

  49. Claghorn, J. L., Mathew, R. J., Weinman, M. L. & Hruska, N. Daytime sleepiness in depression. J. Clin. Psychiatry 42, 342–343 (1981).

    CAS  PubMed  Google Scholar 

  50. Stapleton, S. Etiologies and indicators of powerlessness in persons with end-stage renal disease. In Coping with Chronic Illness: Overcoming Powerlessness (Ed. Miller, J. F.) 163–178 (F. A. Davis, Philadelphia, 1992).

    Google Scholar 

  51. Bliwise, D. L., Kutner, N. G., Zhang, R. & Parker, K. P. Survival by time of day of hemodialysis in an elderly cohort. JAMA 286, 2690–2694 (2001).

    Article  CAS  PubMed  Google Scholar 

  52. McAinsh, J. & Cruickshank, J. M. Beta-blockers and central nervous system side effects. Pharmacol. Ther. 46, 163–197 1990).

    Article  CAS  PubMed  Google Scholar 

  53. Koch, B. C. P. et al. Prescription of hypnotics and potentially sleep-disturbing medication in haemodialysis patients [Dutch]. Pharm. Weekblad 25, 132–134 (2008).

    Google Scholar 

  54. The Merck Manual [online] (2006–2008).

  55. Van Den Heuvel, C. J., Reid, K. J. & Dawson, D. Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. Physiol. Behav. 61, 795–802 (1997).

    Article  CAS  PubMed  Google Scholar 

  56. Brismar, K., Hylander, B., Eliasson, K., Rossner, S. & Wetterberg, L. Melatonin secretion related to side effects of β-blockers from the central nervous system. Acta Med. Scand. 223, 525–530 (1988).

    Article  CAS  PubMed  Google Scholar 

  57. Qureshi, A. & Lee-Chiong, T. Jr. Medications and their effects on sleep. Med. Clin. North Am. 88, 751–766 (2004).

    Article  CAS  PubMed  Google Scholar 

  58. Nagtegaal, J. E., Kerkhof, G. A. & Smits, M. G. Chronobiological, clinical and pharmacological aspects of melatonin in human circadian rhythm dysfunction. In Treatise on Pineal Gland and Melatonin (Eds Haldar, C. et al.) 461–489 (Science Publishers, Enfield, 2002).

    Google Scholar 

  59. Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A. & Busto, U. E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331, 1169–1176 (2005).

    Article  PubMed  PubMed Central  Google Scholar 

  60. Vaziri, N. D. Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int. 50, 653–656 (1996).

    Article  CAS  PubMed  Google Scholar 

  61. Viljoen, M., Steyn, M. E., van Rensburg, B. W. & Reinach, S. G. Melatonin in chronic renal failure. Nephron 60, 138–143 (1992).

    Article  CAS  PubMed  Google Scholar 

  62. Karasek, M., Szuflet, A., Chrzanowski, W., Zylinska, K. & Swietoslawski, J. Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol. Lett. 26, 653–656 (2005).

    CAS  PubMed  Google Scholar 

  63. Karasek, M., Szuflet, A., Chrzanowski, W., Zylinska, K. & Swietoslawski, J. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuro Endocrinol. Lett. 23 (Suppl. 1), 97–102 (2002).

    CAS  PubMed  Google Scholar 

  64. Vaziri, N. D., Oveisi, F., Wierszbiezki, M., Shaw, V. & Sporty, L. D. Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect of hemodialysis. Artif. Organs 17, 764–769 (1993).

    Article  CAS  PubMed  Google Scholar 

  65. Geron, R. et al. Polymorphonuclear leucocyte priming in long intermittent nocturnal haemodialysis patients—is melatonin a player? Nephrol. Dial. Transplant. 21, 3196–3201 (2006).

    Article  CAS  PubMed  Google Scholar 

  66. Souchet, T. et al. Impaired regulation of β-2-adrenergic receptor density in mononuclear cells during chronic renal failure. Biochem. Pharmacol. 35, 2513–2519 (1986).

    Article  CAS  PubMed  Google Scholar 

  67. Holmes, E. W., Hojvat, S. A., Kahn, S. E. & Bermes, E. W. Jr. Testicular dysfunction in experimental chronic renal insufficiency: a deficiency of nocturnal pineal N-acetyltransferase activity. Br. J. Exp. Pathol. 70, 349–356 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Ulfberg, J., Micic, S. & Strøm, J. Afternoon serum-melatonin in sleep disordered breathing. J. Intern. Med. 244, 163–168 (1998).

    Article  CAS  PubMed  Google Scholar 

  69. Hanly, P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin. Dial. 17, 109–114 (2004).

    Article  PubMed  Google Scholar 

  70. Hanly, P., Gabor, J. Y., Chan, C. & Pierratos, A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am. J. Kidney Dis. 41, 403–410 (2003).

    Article  PubMed  Google Scholar 

  71. Ferchland, A. et al. Effects of uremic plasma on α- and β-adrenoceptor subtypes. Nephron 80, 46–50 (1998).

    Article  CAS  PubMed  Google Scholar 

  72. Unruh, M. L., Hartunian, M. G., Chapman, M. M. & Jaber, B. L. Sleep quality and clinical correlates in patients on maintenance dialysis. Clin. Nephrol. 59, 280–288 (2003).

    Article  CAS  PubMed  Google Scholar 

  73. Wide, L., Bengtsson, C. & Birgegård, G. Circadian rhythm of erythropoietin in human serum. Br. J. Haematol. 72, 85–90 (1989).

    Article  CAS  PubMed  Google Scholar 

  74. Koopman, M. G. et al. Circadian rhythm of glomerular filtration rate in normal individuals. Clin. Sci. (Lond.) 77, 105–111 (1989).

    Article  CAS  Google Scholar 

  75. Roberts, D. & Smith, D. J. Erythropoietin does not demonstrate circadian rhythm in healthy men. J. Appl. Physiol. 80, 847–851 (1996).

    Article  CAS  PubMed  Google Scholar 

  76. Buemi, M. et al. The circadian rhythm of erythropoietin in subjects with pre-terminal uremia. Clin. Nephrol. 37, 159–160 (1992).

    CAS  PubMed  Google Scholar 

  77. Hanly, P., Chan, C. & Pierratos, A. The impact of nocturnal hemodialysis on sleep apnea in ESRD patients. Nephrol. News Issues 17, 19–21 (2003).

    PubMed  Google Scholar 

  78. Hanly, P. J. & Pierratos, A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N. Engl. J. Med. 344, 102–107 (2001).

    Article  CAS  PubMed  Google Scholar 

  79. Koch, B. C. et al. Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial. Am. J. Kidney Dis. 53, 658–664 (2009).

    Article  CAS  PubMed  Google Scholar 

  80. Kunz, D. & Bes, F. Exogenous melatonin in periodic limb movement disorder: an open clinical trial and a hypothesis. Sleep 24, 183–187 (2001).

    CAS  PubMed  Google Scholar 

  81. Nagtegaal, J. E., Kerkhof, G. A., Smits, M. G., Swart, A. C. & Van Der Meer, Y. G. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J. Sleep Res. 7, 135–143 (1998).

    Article  CAS  PubMed  Google Scholar 

  82. Andrade, C., Srihari, B. S., Reddy, K. P. & Chandramma, L. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study. J. Clin. Psychiatry 62, 41–45 (2001).

    Article  CAS  PubMed  Google Scholar 

  83. Arendt, J. & Skene, D. J. Melatonin as a chronobiotic. Sleep Med. Rev. 9, 25–39 (2005).

    Article  PubMed  Google Scholar 

  84. Koch, B. C. et al. The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study). Br. J. Clin. Pharmacol. 67, 68–75 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Pérgola, P. E., Habiba, N. M. & Johnson, J. M. Body temperature regulation during hemodialysis in long-term patients: is it time to change dialysate temperature prescription? Am. J. Kidney Dis. 44, 155–165 (2004).

    Article  PubMed  Google Scholar 

  86. Parker, K. P., Bailey, J. L., Rye, D. B., Bliwise, D. L. & Van Someren, E. J. Lowering dialysate temperature improves sleep and alters nocturnal skin temperature in patients on chronic hemodialysis. J. Sleep Res. 16, 42–50 (2007).

    Article  PubMed  Google Scholar 

  87. Ramirez, G., Bittle, P. A., Sanders, H. & Bercu, B. B. Hypothalamo-hypophyseal, thyroid and gonadal function before and after erythropoietin therapy in dialysis patients. J. Clin. Endocrinol. Metab. 74, 517–524 (1992).

    CAS  PubMed  Google Scholar 

  88. Herrera, J., Nava, M., Romero, F. & Rodríguez-Iturbe, B. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am. J. Kidney Dis. 37, 750–757 (2001).

    Article  CAS  PubMed  Google Scholar 

  89. Benz, R. L., Pressman, M. R., Hovick, E. T. & Peterson, D. D. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The Sleepo study). Am. J. Kidney Dis. 34, 1089–1095 (1999).

    Article  CAS  PubMed  Google Scholar 

  90. Zilberman, M. et al. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. Am. Heart J. 154, 870–876 (2007).

    Article  CAS  PubMed  Google Scholar 

  91. Painter, P., Carlson, L., Carey, S., Paul, S. M. & Myll, J. Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am. J. Kidney Dis. 35, 482–492 (2000).

    Article  CAS  PubMed  Google Scholar 

  92. Farese, S. et al. Effect of transcutaneous electrical muscle stimulation and passive cycling movements on blood pressure and removal of urea and phosphate during hemodialysis. Am. J. Kidney Dis. 52, 745–752 (2008).

    Article  PubMed  Google Scholar 

  93. Sakkas, G. K. et al. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO J. 54, 185–190 (2008).

    Article  PubMed  Google Scholar 

  94. Mauvieux, B., Gouthière, L., Sesboüe, B. & Davenne, D. A study comparing circadian rhythm and sleep quality of athletes and sedentary subjects engaged in night work [French]. Can. J. Appl. Physiol. 28, 831–887 (2003).

    Article  PubMed  Google Scholar 

  95. Van Someren, E. J., Riemersma, R. F. & Swaab, D. F. Functional plasticity of the circadian timing system in old age: light exposure. Prog. Brain Res. 138, 205–231 (2002).

    Article  PubMed  Google Scholar 

  96. Campbell, S. S., Dawson, D. & Anderson, M. W. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J. Am. Geriatr. Soc. 41, 829–836 (1993).

    Article  CAS  PubMed  Google Scholar 

  97. Lack, L. et al. The treatment of early-morning awakening insomnia with 2 evenings of bright light. Sleep 28, 616–623 (2005).

    Article  PubMed  Google Scholar 

  98. Friedman, L. et al. Scheduled bright light for treatment of insomnia in older adults. J. Am. Geriatr. Soc. 57, 441–452 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  99. Liu, A. C., Lewis, W. G. & Kay, S. A. l. Mammalian circadian signaling networks and therapeutic targets. Nat. Chem. Biol. 3, 630–639 (2007).

    Article  CAS  PubMed  Google Scholar 

  100. Czeisler, C. A., Buxton, O. M. & Singh Khalsa, S. B. The human circadian timing system and sleep-wake regulation. In Principles and Practice of Sleep Medicine (Eds Kryger, M. H., Roth, T. & Dement, W. C.) 375–394 (Elsevier Saunders, Philadelphia, 2005).

    Chapter  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Dutch Kidney Foundation for supporting our work and Inzicht Graphic Design, Arnhem, The Netherlands, for their assistance with the figures.

Charles P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Birgit C. P. Koch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Koch, B., Nagtegaal, J., Kerkhof, G. et al. Circadian sleep–wake rhythm disturbances in end-stage renal disease. Nat Rev Nephrol 5, 407–416 (2009). https://doi.org/10.1038/nrneph.2009.88

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2009.88

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing